Cytyc to increase marketing pressure on rivals
This article was originally published in Clinica
Cervical smear company Cytyc is to step up development of its ThinPrep computer imaging system to complement its ThinPrep slide processing system and counter the threat of increased competition in the enhanced Pap smear market. Cytyc has completed feasibility studies on the product and has teamed up with technology development company Battelle's medical products group.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.